Skip to main content

Table 1 Study demographics

From: The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites

 

Total sampled

Humans only

Humans and pets

Pets only

Baseline study visit

    

 Households

    

  Number of households

25

3

4

18

  Number of people, median (range)

4 (1–8)

4 (2–5)

5 (4–7)

4 (1–8)

  Number of pets, median (range)

2 (0–13)

0

2 (1–10)

2 (1–13)

 Human subjects

    

Index subjects

6

3

3

-

  Female:male

3:3

2:1

1:2

-

  Age in years, median (range)

8.5 (2–48)

5 (2–48)

13 (6–15)

-

  CPS + at any site, n = 4

3

1

2

 

  S. aureus + at any site, n = 4

1

1

0

 

  MRSA + at any site

1

1

0

-

 Non-index subjects

24

7

17

-

  Female:male

12:12

4:3

8:9

-

  Age in years, median (range)

25 (3–54)

23 (9–42)

26 (3–54)

-

  CPS + at any site, n = 18

15

1

14

 

  S. aureus + at any site, n = 18

3

0

3

 

  MRSA + at any site

3

0

3

-

 Pet subjects

    

  Dogs

36

-

5

31

  Female:male

21:15

-

3:2

18:13

  Age in months, median (range)

24 (2–132)

-

24 (6–120)

24 (2–132)

  Neutered:unneutered

9:27

-

1:4

8:23

  CPS + at any site

34

-

4

30

  S. aureus + at any site

6

-

1

5

  MRSA + at any site

2

-

2

0

 Cats

20

-

3

17

  Female:male

11:9

-

3:0

8:9

  Age in months, median (range)

27 (4–135)

-

12 (8–20)

53 (4–135)

  Neutered:unneutered

16:4

-

2:1

14:3

  CPS + at any site

13

-

2

11

  S. aureus + at any site

4

-

1

3

  MRSA + at any site

2

-

2

0

Three-month follow-up study visit

    

  Households

    

 Number of households

20

2

3

15

  Number randomized to treatment

12

2

2

8

  Number of people, median (range)

4 (1–8)

4.5 (4–5)

5 (4–7)

4 (1–8)

  Number of pets, median (range)

2 (0–10)

0

2 (1–8)

3 (1–10)

 Human subjects

    

  Index subjects

4

2

2

-

 Randomized to treatment

3

2

1

-

 Female:male

1:3

1:1

0:2

-

 Age in years, median (range)

9 (2–15)

3.5 (2–5)

14 (13–15)

-

 CPS + at any site, n = 4

3

0

3

 

  S. aureus + at any site, n = 4

1

0

1

 

 MRSA + at any site

0

0

0

-

 Non-index subjects

17

6

11

-

  Randomized to treatment

14

6

8

 

  Female:male

8:9

3:3

5:6

-

  Age in years, median (range)

26 (3–54)

21 (9–42)

26 (3–54)

-

  CPS + at any site, n = 14

11

3

8

 

  S. aureus + at any site, n = 14

4

1

3

 

  MRSA + at any site

0

0

0

-

 Pet subjects

    

  Dogs

19

-

4

15

  Female:male

12:7

-

2:2

10:5

  Age in months, median (range)

37 (6–132)

-

42 (6–120)

37 (9–132)

  Neutered:unneutered

7:12

-

1:3

6:9

  CPS + at any site

17

-

3

14

  S. aureus + at any site

4

 

0

4

  MRSA + at any site

3

-

0

3

 Cats

14

-

2

12

  Female:male

8:6

-

2:0

6:6

  Age in months, median (range)

15 (4–135)

-

10 (8–12)

23 (4–135)

  Neutered:unneutered

10:4

-

1:1

9:3

  CPS + at any site

11

-

1

10

  S. aureus + at any site

4

 

0

4

  MRSA + at any site

1

-

0

1

  1. For pet-only households, humans were present, but were not eligible for participation. Data from the 3-month follow-up visit are limited to people and pets sampled longitudinally, excluding new household members present at the 3-month visit.